Hemostasis Today

November, 2026
November 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Asmaa Beltagy: Efficacy and Safety of Eltrombopag in SLE-Associated Immune Thrombocytopenia
Nov 15, 2026, 20:50

Asmaa Beltagy: Efficacy and Safety of Eltrombopag in SLE-Associated Immune Thrombocytopenia

Asmaa Beltagy, Lecturer and Attending of Internal Medicine and Rheumatology at Alexandria University Faculty of Medicine, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Lupus, adding:

“Happy to share that our paper has been accepted in Lupus!

‘Eltrombopag in the treatment of immune thrombocytopenia secondary to SLE: A double-edged sword’

We looked at both the efficacy and the safety of eltrombopag in SLE-associated immune thrombocytopenia, with a particular focus on thrombotic risk, a question that matters at the bedside when we reach for this drug in patients who may already be prothrombotic.

Huge thanks to my co-authors for their work and collaboration on this project.

Grateful to keep contributing to lupus research.”

Title: Eltrombopag in the treatment of immune thrombocytopenia secondary to SLE: A double-edged sword

Authors: Asmaa Beltagy, Abeer Abdelati, Fatma Fayed, Nouran Eshak, Ashraf Elghandour, Mohamed H. Elbahoty

Asmaa Beltagy

Stay updated on all scientific advances with Hemostasis Today.